Mechanism for Potential Friedreich’s Ataxia Drug Uncovered
By Frontier India Pharmacetuicals News | September 25th, 2009 | Category: Medical Institution News, Medical R&D News | No Comments »Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich’s ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, help advance this treatment approach one step closer toward human [...]
